Today marks our next step in reducing financial barriers to care for all treatments and patient populations. We are now joined by strategic investors Citi, OSF Ventures, and American Cancer Society’s impact investment fund, BrightEdge. Founded with a personal mission to help patients and the US health care industry tackle the financial challenges of care delivery, TailorMed is focused on ensuring all patients across all medical conditions can afford treatment. Through our continued innovation and growth, and the support from this band of forward-thinking investors, we’ll tackle the high cost of health care like no other company in the industry.
Read more to learn how we’re moving mountains for patients and improving financial performance for healthcare organizations.
